Regulation of ovarian function by growth hormone: Potential intervention of ovarian aging.

diminished ovarian reserve (DOR) growth hormone in vitro fertilization ovarian aging (OA) poor ovarian response (POR)

Journal

Frontiers in endocrinology
ISSN: 1664-2392
Titre abrégé: Front Endocrinol (Lausanne)
Pays: Switzerland
ID NLM: 101555782

Informations de publication

Date de publication:
2022
Historique:
received: 17 10 2022
accepted: 08 12 2022
entrez: 26 1 2023
pubmed: 27 1 2023
medline: 28 1 2023
Statut: epublish

Résumé

Growth hormone (GH) is mainly secreted by eosinophils of anterior pituitary gland. GH plays an important role in regulating the growth and development of many tissues and cells, so it is used in the treatment of many diseases. In recent years, the regulation of GH on ovarian function has attracted much attention. GH has been applied in controlled ovarian hyperstimulation, particularly in the patients with advanced age, diminished ovarian reserve (DOR) and poor ovarian response (POR). GH can directly bind to the growth hormone receptor (GHR) on the ovary to promote the growth, maturation and ovulation of follicles, as well as to inhibit follicular atresia. GH so as to promote the occurrence of early follicles, enhance the sensitivity of follicles to gonadotropins, accelerate the maturation of oocyte nucleus, improve mitochondrial activity and the quality of oocytes through the insulin-like growth factor (IGF) system, which is an indirect regulation. The deep-seated effects of GH on human reproduction and ovarian aging need further basic research and clinical practice.

Identifiants

pubmed: 36699044
doi: 10.3389/fendo.2022.1072313
pmc: PMC9868403
doi:

Substances chimiques

Growth Hormone 9002-72-6
Human Growth Hormone 12629-01-5

Types de publication

Journal Article Review Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1072313

Informations de copyright

Copyright © 2023 Han, Tian, Guo and Zhang.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Protein Pept Lett. 2020;27(12):1260-1267
pubmed: 32543356
Int J Mol Sci. 2022 Sep 15;23(18):
pubmed: 36142677
Front Endocrinol (Lausanne). 2019 Jul 16;10:450
pubmed: 31379735
Reprod Sci. 2021 Apr;28(4):936-948
pubmed: 33078329
Endocrine. 2017 May;56(2):267-278
pubmed: 27815769
Front Endocrinol (Lausanne). 2019 Jul 24;10:485
pubmed: 31396155
Front Endocrinol (Lausanne). 2018 Jun 29;9:327
pubmed: 30008696
Reproduction. 2018 Apr 1;157(4):345-358
pubmed: 30668522
Front Physiol. 2022 Jun 13;13:859790
pubmed: 35770187
Aging (Albany NY). 2021 Feb 17;13(5):6765-6781
pubmed: 33621201
Proc Natl Acad Sci U S A. 2013 Aug 27;110(35):E3331-9
pubmed: 23940366
Fertil Steril. 2016 Mar;105(3):697-702
pubmed: 26690008
Anim Biotechnol. 2021 Dec 6;:1-14
pubmed: 34871537
Cochrane Database Syst Rev. 2021 Nov 22;11:CD000099
pubmed: 34808697
Hum Reprod. 2017 Apr 1;32(4):905-914
pubmed: 28158425
J Hum Reprod Sci. 2022 Jul-Sep;15(3):284-292
pubmed: 36341006
Maedica (Bucur). 2022 Jun;17(2):336-343
pubmed: 36032602
Cochrane Database Syst Rev. 2010 Jan 20;(1):CD000099
pubmed: 20091500
Front Endocrinol (Lausanne). 2022 Jul 14;13:920482
pubmed: 35909559
Cell Tissue Res. 2011 Jul;345(1):191-202
pubmed: 21618141
Monaldi Arch Chest Dis. 2018 Sep 05;88(3):989
pubmed: 30183159
Best Pract Res Clin Endocrinol Metab. 2015 Oct;29(5):671-83
pubmed: 26522453
Clin Endocrinol (Oxf). 2014 Jul;81(1):1-14
pubmed: 24750271
Cell Tissue Res. 2014 Jul;357(1):363-72
pubmed: 24744268
Aging (Albany NY). 2019 Dec 13;11(23):11504-11519
pubmed: 31834867
Mol Cell Endocrinol. 2021 Jan 1;519:111044
pubmed: 33053393
Hum Reprod Update. 2022 Nov 2;28(6):838-857
pubmed: 35641113
Am J Physiol Endocrinol Metab. 2018 Dec 1;315(6):E1232-E1241
pubmed: 30130150
Front Endocrinol (Lausanne). 2020 Nov 18;11:597573
pubmed: 33312162
Front Endocrinol (Lausanne). 2020 Feb 25;11:33
pubmed: 32158429
Ann Endocrinol (Paris). 2021 Dec;82(6):590-596
pubmed: 34186075
Reprod Biol. 2021 Jun;21(2):100504
pubmed: 33839528
Front Endocrinol (Lausanne). 2021 Sep 01;12:720419
pubmed: 34539573
Fertil Steril. 2020 Jul;114(1):97-109
pubmed: 32553470
J Assist Reprod Genet. 2020 Nov;37(11):2743-2756
pubmed: 32935173
Sci Rep. 2020 Oct 30;10(1):18769
pubmed: 33127971
Gen Comp Endocrinol. 2013 Jun 1;186:150-6
pubmed: 23510860
J Assist Reprod Genet. 2021 May;38(5):1055-1060
pubmed: 33534048
Front Endocrinol (Lausanne). 2019 Jun 26;10:404
pubmed: 31297089
Front Endocrinol (Lausanne). 2018 Feb 13;9:35
pubmed: 29487568

Auteurs

Lei Han (L)

Department of Reproductive Medicine, Binzhou Medical University Hospital, Binzhou, Shandong, China.
Department of Reproductive Medicine, Maternal and Child Health Hospital Affiliated to Zunyi Medical University, Zunyi, Guizhou, China.

Hongcheng Tian (H)

Department of Reproductive Medicine, Binzhou Medical University Hospital, Binzhou, Shandong, China.

Xiaoxiao Guo (X)

Department of Reproductive Medicine, Binzhou Medical University Hospital, Binzhou, Shandong, China.

Lei Zhang (L)

Department of Endocrinology, Binzhou Medical University Hospital, Binzhou, Shandong, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH